San Francisco, Calif. -- King Pharmaceuticals announces the discontinuation of Tilade Inhaler (nedocromil sodium inhalation aerosol). The drug is being discontinued for a variety of reasons, including the company’s inability to identify a qualified manufacturer for a chlorofluorocarbon propellant inhaler. TILADE(R) will remain available through pharmacies and wholesalers until current supplies are depleted.
To view a letter from the company, please visit: http://www.fda.gov/cder/drug/shortages/Tilade_DHCPApril2008.pdf
Contact: Suvarna Bhatt at sbhatt@biospace.com.
